von Koch, S., Koul, S., Grimfjärd, P., Andersson, J., Jernberg, T., Omerovic, E.
, Fröbert, O., Erlinge, D. & Mohammad, M. A. (2024).
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry.
Heart,
110(22), 1307-1315.
https://doi.org/10.1136/heartjnl-2024-324307von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J.
, Hansen, T. K., Mathieu, C., Morales, C., Mosenzon, O., Segel, S., Tsoukas, G., Pieber, T. R. & Anti-IL-21–liraglutide Study Group investigators and contributors (2021).
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet Diabetes & Endocrinology,
9(4), 212-224.
https://doi.org/10.1016/S2213-8587(21)00019-XVoigt, J. H., Lauritsen, K. M.
, Pedersen, S. B., Hansen, T. K., Møller, N., Jessen, N., Laurenti, M. C., Dalla Man, C., Vella, A.
, Gormsen, L. C. & Søndergaard, E. (2024).
Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes.
Basic & Clinical Pharmacology & Toxicology,
134(5), 643-656.
https://doi.org/10.1111/bcpt.13991
Vlk, E.
, Ebbehoj, A., Donskov, F., Poulsen, P. L., Rashu, B. S., Bro, L., Aagaard, M.
& Rolighed, L. (2022).
Outcome and prognosis after adrenal metastasectomy: nationwide study.
BJS Open,
6(2), Article zrac047.
https://doi.org/10.1093/bjsopen/zrac047Vlasselaers, D., Mesotten, D., Langouche, L., Vanhorebeek, I., van den Heuvel, I., Milants, I., Wouters, P., Wouters, P., Meyns, B.
, Bjerre, M., Hansen, T. K. & Van den Berghe, G. (2010).
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery.
Annals of Thoracic Surgery,
90(1), 22-9.
https://doi.org/10.1016/j.athoracsur.2010.03.093Vladimirova, Y. V., Mølmer, M. K., Antonsen, K. W., Møller, N., Rittig, N., Nielsen, M. C. & Møller, H. J. (2022).
A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRP alpha).
Biomolecules,
12(7), Article 937.
https://doi.org/10.3390/biom12070937
Vlachová, Z., Bytoft, B.
, Knorr, S., Clausen, T. D., Jensen, R. B., Mathiesen, E. R.
, Højlund, K., Ovesen, P., Beck-Nielsen, H.
, Gravholt, C. H., Damm, P. & Jensen, D. M. (2015).
Increased metabolic risk in adolescent offspring of mothers with type 1 diabetes: The EPICOM study.
Diabetologia,
58(7), 1454-63.
https://doi.org/10.1007/s00125-015-3589-5Viuff, M. H., Krag, K. S., Uldbjerg, N., Nielsen, B. B., Gravholt, C. H. & Danish Fetal Medicine Study Group (2015).
Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
Human reproduction (Oxford, England),
30(10), 2419-26.
https://doi.org/10.1093/humrep/dev192